Hypovitaminosis D and Morbid Obesity

Nursing Clinics of North America

Volumn 42, Issue 1, 2007, Pages 19-27

  Ybarra, Juan ^a   Sánchez Hernández, Joan ^a,b   Pérez, Antonio ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

BARIATRIC SURGERY; DIET SUPPLEMENTATION; HUMAN; MORBID OBESITY; NURSING; POSTOPERATIVE COMPLICATION; REVIEW; VITAMIN D DEFICIENCY;

BARIATRIC SURGERY; CALCIUM; DIETARY SUPPLEMENTS; HUMANS; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33846550020     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.12.001     Document Type: Review

References (40)

1. Chapin B.L., LeMar H.J., Knodel D.H., et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg 113 (1996) 1048-1052
2. Guangiroli M. Cirugías malabsortivas (2004), Facultad Favoloro Argentina Press, Argentina
3. Marsh M., and Ryley S. Enfermedades gastrointestinales y hepáticas. Panamericana (1998) cap 87:1577-1608
4. Goldner W., O'Dorisio T., Dillon J., et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 12 (2002) 685-692
5. Basha B., Rao S., Han Z., et al. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 108 (2000) 296-300
6. Kawashima H., and Kurokawa K. Metabolism and sites of action of vitamin D in the kidney. Kidney Int 29 (1986) 98-107
7. Kumar R. The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. Kidney Int 30 (1986) 793-803
8. Reichel H., Koeffler H.P., and Norman A.W. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320 (1989) 980
9. Norman A.W., Roth J., and Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3 (1982) 331
10. DeLuca H.F., Krisinger J., and Darwish H. The vitamin D system: 1990. Kidney Int 38 Suppl 29 (1990) S2-S8
11. MacIntyre I., Alevizaki M., Bevis P.J.R., et al. Calcitonin and the peptides from the calcitonine gene. Clin Orthop 217 (1987) 45-55
12. Delmez JA, Slatopolsky E. Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1991;72:735.
13. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
14. MacKenna M., and Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8 Suppl (1998) S3-S6
15. Wortsman J., Matsuoka L.Y., Chen T.C., et al. Decreased bioavailability of vitamin D in obesity. Am J Nutr 72 (2000) 690-693
16. Holick M.F. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9 (2002) 87-98
17. Chapuy M.C., Shott A.M., Garnero P., et al. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. Endocrinol Metab 81 (1996) 1129-1133
18. Bell N.H., Epstein S., Greene A., et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76 (1985) 370-373
19. Liel Y., Ulmer E., Shary J., et al. Low circulating vitamin D in obesity. Calcif Tissue Int 43 (1988) 199-201
20. Compston J.E., Vedi S., Ledger J.E., et al. Vitamin D status and bone histomorphometry in gross obesity. Am J Nutr 34 (1981) 2359-2363
21. Hey H.E., Stockholm K.H., Lun B.J., et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolism following jejunoileal bypass. Int J Obes 6 (1982) 473-479
22. Hyldstrup L., Andersen T., McNair P., et al. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh) 129 (1993) 393-398
23. Ybarra J., Sánchez-Hernández J., Gich I., et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 15 (2005) 330-335
24. Sánchez-Hernández J., Ybarra J., Gich I., et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 15 (2005) 1389-1395
25. Buffington C., Walker B., Cowan Jr. G.S., et al. Vitamin D deficiency in the morbidly obese. Obes Surg 3 4 (1993) 421-424
26. Heaney R.P., Davies K.M., and Barger-Lux M.J. Calcium and weight: clinical studies. J Am Coll Nutr 21 2 (2002) 152S-155S
27. Kamycheva E., Sundsfjord J., and Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso Study. Eur J Endocrinol 151 2 (2004) 167-172
28. Liu S., Song Y., Ford E.S., et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28 (2005) 2926-2932
29. Holick MF. Calcium and vitamin D. Diagnostics and therapeutics. Clin Lab Med 2000;20:569-90.
30. De Prisco C., and Levine S.N. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med 118 (2005) 51-57
31. Ping-Delfos W.C., Soares M.J., and Cummings N.K. Acute suppression of spontaneous food intake following dairy calcium and vitamin D. Asia Pac J Clin Nutr 13 Suppl (2004) S82
32. Compston J.E., Vedi S., Gianetta E., et al. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology 87 2 (1984) 350-356
33. Scopinaro N, Adami GF, Marinari G, et al. Biliopancreatic diversion: two decades of experience. In: Update: surgery for the morbidly obese patient. 2000. p. 227-58.
34. Guney E., Kisakol G., Yilmaz C., et al. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 13 (2003) 383-388
35. Teitelbaum S.L., Halverson J.D., Bates M., et al. Abnormalities of circulating 25-OH vitamin D after jejuno-ileal bypass for obesity. Ann Intern Med 86 (1977) 289-293
36. Compston J.E., Laker M.F., Woodhead J.S., et al. Bone disease after jejunoileal bypass for obesity. Lancet 2 (1978) 1-4
37. Parfitt A.M., Miller J.M., Frame B., et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 89 (1978) 193-199
38. Hey H., Stokholm K.H., Lund B.J., et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 6 (1982) 473-479
39. Hamoui N., Kim K., Anthone G., et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 138 (2003) 891-897
40. Newbury L., Dolan K., Hatzifotis M., et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 13 (2003) 893-895